North Macedonia vs Seychelles: Share of adolescent girls vaccinated against human papillomavirus
North Macedonia
21.0%
in 2024
Seychelles
23.0%
in 2024
North Macedonia rank
67th
Seychelles rank
65th
Share of adolescent girls vaccinated against human papillomavirus over time
- North Macedonia
- Seychelles
How they compare
Seychelles currently reports 23.0% against 21.0% in North Macedonia, a difference of 2.0%.
That makes Seychelles's figure about 1.1 times North Macedonia's.
Across all 7 years both countries report, Seychelles has been ahead every year.
North Macedonia ranks 67th and Seychelles ranks 65th of 74 countries.
Seychelles has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Seychelles | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 40.0% | 79.5% | 39.5% | Seychelles |
| 2020s | 35.0% | 68.2% | 33.2% | Seychelles |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, North Macedonia or Seychelles?
- Seychelles, at 23.0% against 21.0% in North Macedonia as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between North Macedonia and Seychelles?
- 2.0%, with Seychelles ahead.
- How many years of comparable data are there for North Macedonia and Seychelles?
- 7 years are reported by both, from 2018 to 2024.
- How do North Macedonia and Seychelles rank globally for share of adolescent girls vaccinated against human papillomavirus?
- North Macedonia ranks 67th and Seychelles ranks 65th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.